MST3-IN-1
MST3-IN-1 is a selective and orally active MST3 inhibitor, with an IC50 of 122.4 nM. MST3-IN-1 shows antiproliferative activity against HepG2 cell. MST3-IN-1 effectively induces apoptosis in HepG2 cells, and halts the cell cycle at the G2/M transition. MST3-IN-1 significantly suppressed tumor growth in HepG2 xenograft mice. MST3-IN-1 can be used for the study of liver cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3095435-97-2
- 分子式: C25H21F4N5O3S
- 分子量:547.52
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Caspase アイソフォーム固有の製品をすべて表示
More
生物活性
MST3-IN-1 (Compound LD-1) exhibits antiproliferative activities to cancer cell lines with GI50s of 0.68 μM (HepG2 cells), 0.77 μM (HCT116 cells) and 0.83 μM (H226 cells) and inhibits HK2 cells are all greater than 30 μM, showing good selectivity[1]. MST3-IN-1 (1 μM) shows an inhibition rate of 95.49 % against MST3, and the inhibition rate against the secondranked kinase, AKT2, is only 66.51 %[1]. MST3-IN-1 (0.25-2 μM, 24 h) induces apoptosis in HepG2 cells and may inhibit HepG2 cells proliferation by prolonging the G2/M phase[1]. MST3-IN-1 (0.25-2 μM, 24 h) reduces the expression level of p-MST3 in a concentration-dependent manner and does not affect the expression level of MST3[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 cells
-
Concentration:0.5, 1, 2 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in HepG2 cells.
-
Cell Line:HepG2 cells
-
Concentration:0.5, 1, 2 μM
-
Incubation Time:48 h
-
Result:Revealed distinct morphological characteristics of apoptosis, including chromatin condensation and nuclear fragmentation.
-
Cell Line:HepG2 cells
-
Concentration:0.25, 0.5, 1 μM
-
Incubation Time:24 h
-
Result:Increased the proportion of cells at the G2/M phase.
-
Cell Line:HepG2 cells
-
Concentration:0.33, 1, 3 μM
-
Incubation Time:24 h
-
Result:Reduced the expression level of p-MST3.
Increased the expression level of cleaved caspase-3.
Reduced the expression levels of caspase-3 and Bcl-2.
Did not affect the expression level of MST3.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HepG2 cells (5 × 106) were injected subcutaneously into the right armpit of the mice[1]
-
Dosage:40 mg/kg
-
Administration:i.g. daily for 15 days
-
Result:Exhibited a significant tumor growth inhibition (TGI) rate of 47.64%, outperforming the current first-line treatment agent Sorafenib (HY-10201) (TGI = 32.52%). Showed no mouse mortality or significant body weight loss was observed across all dosage groups.
化学情報
-
CAS 番号 3095435-97-2
-
分子量 547.52
-
分子式 C25H21F4N5O3S
-
SMILES
O=C(C1=CN(C2CC2)C3=CC(N4CCNCC4)=C(C=C3C1=O)F)NC5=NC6=C(S5)C=C(OC(F)(F)F)C=C6
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
MST3-IN-1 関連分類
HY-175208 関連分類
Powered by Bioz